Engineered biomaterial and biophysical stimulation as combinatorial strategies to address prosthetic infection by pathogenic bacteria

Journal of Biomedical Materials Research - Part B Applied Biomaterials

Volumn 105, Issue 7, 2017, Pages 2174-2190

  Boda, Sunil Kumar ^a   Basu, Bikramjit ^a  

^a INDIAN INSTITUTE OF SCIENCE   (India)

Author keywords

antimicrobial; biophysical methods; magnetic and electric field; prosthetic infection; ultrasound

Indexed keywords

ANTIBIOTICS; ANTIMICROBIAL AGENTS; BIOMATERIALS; BIOPHYSICS; ELECTRIC FIELDS; MICROORGANISMS; PROSTHETICS; ULTRASONICS;

ANTIMICROBIAL; BIOPHYSICAL METHODS; BIOPHYSICAL STIMULATION; COMBINATORIAL STRATEGIES; ELECTRIC AND MAGNETIC FIELDS; HOSPITAL ACQUIRED INFECTION; MAGNETIC AND ELECTRIC FIELDS; THERAPEUTIC APPLICATION;

BACTERIA;

ANTIINFECTIVE AGENT; BIOMATERIAL; NANOPARTICLE; REACTIVE OXYGEN METABOLITE; BIOCOMPATIBLE COATED MATERIAL;

ANTIBACTERIAL ACTIVITY; ANTIBIOTIC RESISTANCE; ANTIMICROBIAL THERAPY; BACTERIAL GROWTH; BACTERIAL MEMBRANE; BACTERIUM ADHERENCE; BIOCOMPATIBILITY; BIOENGINEERING; BIOFILM; ELECTRIC FIELD; HUMAN; INFECTION PREVENTION; MAGNETIC FIELD; MATERIAL COATING; MEMBRANE DEPOLARIZATION; MICROBIAL CONTAMINATION; NONHUMAN; OXIDATION REDUCTION REACTION; PROSTHESIS INFECTION; RECURRENT INFECTION; REVIEW; STAPHYLOCOCCUS; STIMULATION; ULTRASOUND; ANIMAL; CHEMISTRY; GROWTH, DEVELOPMENT AND AGING; METABOLISM; MICROBIOLOGY; PATHOLOGY; PROSTHESES AND ORTHOSES; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS INFECTION;

ANIMALS; ANTI-INFECTIVE AGENTS; COATED MATERIALS, BIOCOMPATIBLE; HUMANS; NANOPARTICLES; PROSTHESES AND IMPLANTS; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS;

EID: 84978208775     PISSN: 15524973     EISSN: 15524981     Source Type: Journal    
DOI: 10.1002/jbm.b.33740     Document Type: Review

References (124)

1. Basu B, Katti DS, Kumar A. Advanced Biomaterials: Fundamentals, Processing, and Applications. New Jersey: John Wiley & Sons Ltd; 2009.
2. Widmer AF. New developments in diagnosis and treatment of infection in orthopedic implants. Clin Infect Dis 2001; 33(Suppl 2):S94–S106.
3. Harris LG, Foster SJ, Richards RG. An introduction to Staphylococcus aureus, and techniques for identifying and quantifying S. aureus adhesins in relation to adhesion to biomaterials: review. Eur Cell Mater 2002; 4:39–60.
4. Zmistowski B, Tetreault MW, Alijanipour P, Chen AF, Della Valle CJ, Parvizi J. Recurrent periprosthetic joint infection: Persistent or new infection? J Arthroplasty 2013; 28:1486–1489.
5. Moriarty TF, Poulsson AHC, Rochford ETJ, Richards RG, Editor-in-Chief: Â Â Paul D: 4.407 - bacterial adhesion and biomaterial surfaces. In: Comprehensive Biomaterials. Oxford: Elsevier. pp 75–100.
6. Abu-Lail NI, Beyenal H, Amit B, Susmita B: Chapter 5.2—Characterization of bacteria—Biomaterial interactions, from a single cell to biofilms. In: Characterization of Biomaterials. Oxford: Academic Press. pp 207–253.
7. Vani K, Thomas S, Prabhawathi V, Boobalan T, Sawant SN, Doble M. In vitro biocompatiblity of modified polycarbonate as a biomaterial. Colloids Surf B Biointerfaces 2013; 108(C):191–198.
8. Katsikogianni M, Missirlis YF. Concise review of mechanisms of bacterial adhesion to biomaterials and of techniques used in estimating bacteria-material interactions. Eur Cell Mater 2004; 8:37–57.
9. Hudson MC, Ramp WK, Frankenburg KP. Staphylococcus aureus adhesion to bone matrix and bone-associated biomaterials. FEMS Microbiol Lett 1999; 173:279–284.
10. Busscher HJ, van der Mei HC, Subbiahdoss G, Jutte PC, van den Dungen JJ, Zaat SA, Schultz MJ, Grainger DW. Biomaterial-associated infection: locating the finish line in the race for the surface. Sci Transl Med 2012; 4:153rv10.
11. Albelda SM, Buck CA. Integrins and other cell adhesion molecules. FASEB J 1990; 4:2868–2880.
12. Mack D, Becker P, Chatterjee I, Dobinsky S, Knobloch JKM, Peters G, Rohde H, Herrmann M. Mechanisms of biofilm formation in Staphylococcus epidermidis and Staphylococcus aureus: functional molecules, regulatory circuits, and adaptive responses. Int J Med Microbiol 2004; 294:203–212.
13. Brown MR, Collier PJ, Gilbert P. Influence of growth rate on susceptibility to antimicrobial agents: modification of the cell envelope and batch and continuous culture studies. Antimicrob Agents Chemother 1990; 34:1623–1628.
14. Miller MB, Bassler BL. Quorum sensing in bacteria. Annu Rev Microbiol 2001; 55:165–199.
15. Rutherford ST, Bassler BL. Bacterial quorum sensing: its role in virulence and possibilities for its control. Cold Spring Harb Perspect Med 2012; 2(11):pii: a012427.
16. Welsh MA, Eibergen NR, Moore JD, Blackwell HE. Small molecule disruption of quorum sensing cross-regulation in pseudomonas aeruginosa causes major and unexpected alterations to virulence phenotypes. J Am Chem Soc 2015; 137:1510–1519.
17. Lebeaux D, Ghigo JM, Beloin C. Biofilm-related infections: bridging the gap between clinical management and fundamental aspects of recalcitrance toward antibiotics. Microbiol Mol Biol Rev 2014; 78:510–543.
18. Lewis K. Platforms for antibiotic discovery. Nat Rev Drug Discov 2013; 12:371–387.
19. Wilke MS, Lovering AL, Strynadka NC. Beta-lactam antibiotic resistance: a current structural perspective. Curr Opin Microbiol 2005; 8:525–533.
20. Jernaes MW, Steen HB. Staining of Escherichia coli for flow cytometry: influx and efflux of ethidium bromide. Cytometry 1994; 17:302–309.
21. Radecka I, Martin C and Hill D. Novel Antimicrobial Agents and Strategies, Wiley-VCH Verlag GmbH & Co. KGaA, pp. 1–16.
22. Pendleton JN, Gorman SP, Gilmore BF. Clinical relevance of the ESKAPE pathogens. Exp Rev Anti Infect Ther 2013; 11:297–308.
23. Song R, Yan J, Xu S, Wang Y, Ye T, Chang J, Deng H, Li B. Silver ions/ovalbumin films layer-by-layer self-assembled polyacrylonitrile nanofibrous mats and their antibacterial activity. Colloids Surf B Biointerfaces 2013; 108:322–328.
24. Mei L, Lu Z, Zhang X, Li C, Jia Y. Polymer-Ag nanocomposites with enhanced antimicrobial activity against bacterial infection. ACS Appl Mater Interfaces 2014; 6:15813–15821.
25. Boda SK, Broda J, Schiefer F, Weber-Heynemann J, Hoss M, Simon U, Basu B, Jahnen-Dechent W. Cytotoxicity of ultrasmall gold nanoparticles on planktonic and biofilm encapsulated gram-positive Staphylococci. Small 2015; 11:3183–3193.
26. Lemire JA, Harrison JJ, Turner RJ. Antimicrobial activity of metals: mechanisms, molecular targets and applications. Nat Rev Microbiol 2013; 11:371–384.
27. Prabhu S, Poulose EK. Silver nanoparticles: mechanism of antimicrobial action, synthesis, medical applications, and toxicity effects. International Nano Letters 2012; 2:1–10.
28. Lansdown AB. Silver in health care: antimicrobial effects and safety in use. Curr Probl Dermatol 2006; 33:17–34.
29. Santo CE, Lam EW, Elowsky CG, Quaranta D, Domaille DW, Chang CJ, et al. Bacterial killing by dry metallic copper surfaces. Appl Environ Microbiol 2011; 77:794–802.
30. Glisic BD, Djuran MI. Gold complexes as antimicrobial agents: an overview of different biological activities in relation to the oxidation state of the gold ion and the ligand structure. Dalton Trans 2014; 43:5950–5969.
31. Boda SK, Pandit S, Garai A, Pal D, Basu B. Bacterial siderophore mimicking iron complexes as DNA targeting antimicrobials. RSC Adv 2016; 6:39245–39260.
32. Arakha M, Pal S, Samantarrai D, Panigrahi TK, Mallick BC, Pramanik K, Mallick B, Jha S. Antimicrobial activity of iron oxide nanoparticle upon modulation of nanoparticle-bacteria interface. Sci Rep 2015; 5:14813.
33. Dalai S, Pakrashi S, Kumar RSS, Chandrasekaran N, Mukherjee A. A comparative cytotoxicity study of TiO2 nanoparticles under light and dark conditions at low exposure concentrations. Toxicol Res 2012; 1:116–130.
34. Nair S, Sasidharan A, Divya Rani VV, Menon D, Manzoor K, Raina S. Role of size scale of ZnO nanoparticles and microparticles on toxicity toward bacteria and osteoblast cancer cells. J Mater Sci Mater Med 2009; 20(Suppl 1):S235–S241.
35. Aydin Sevinc B, Hanley L. Antibacterial activity of dental composites containing zinc oxide nanoparticles. J Biomed Mater Res B Appl Biomater 2010; 94:22–31.
36. Hajipour MJ, Fromm KM, Akbar Ashkarran A, Jimenez de Aberasturi D, Larramendi IRd, Rojo T, Serpooshan V, Parak WJ, Mahmoudi M. Antibacterial properties of nanoparticles. Trends Biotechnol 2012; 30:499–511.
37. Kim HW, Knowles JC, Kim HE. Hydroxyapatite porous scaffold engineered with biological polymer hybrid coating for antibiotic Vancomycin release. J Mater Sci Mater Med 2005; 16:189–195.
38. Badar M, Rahim MI, Kieke M, Ebel T, Rohde M, Hauser H, Behrens P, Mueller PP. Controlled drug release from antibiotic-loaded layered double hydroxide coatings on porous titanium implants in a mouse model. J Biomed Mater Res A 2015; 103:2141–2149.
39. Gimeno M, Pinczowski P, Perez M, Giorello A, Martinez MA, Santamaria J, Arruebo M, Lujan L. A controlled antibiotic release system to prevent orthopedic-implant associated infections: An in vitro study. Eur J Pharm Biopharm 2015; 96:264–271.
40. Schairer DO, Chouake JS, Nosanchuk JD, Friedman AJ. The potential of nitric oxide releasing therapies as antimicrobial agents. Virulence 2012; 3:271–279.
41. Friedman AJ, Blecher K, Schairer D, Tuckman-Vernon C, Nacharaju P, Sanchez D, Gialanella P, Martinez LR, Friedman JM, Nosanchuk JD. Improved antimicrobial efficacy with nitric oxide releasing nanoparticle generated S-nitrosoglutathione. Nitric Oxide 2011; 25:381–386.
42. Carpenter AW, Worley BV, Slomberg DL, Schoenfisch MH. Dual action antimicrobials: Nitric oxide release from quaternary ammonium-functionalized silica nanoparticles. Biomacromolecules 2012; 13:3334–3342.
43. Afzal MA, Kalmodia S, Kesarwani P, Basu B, Balani K. Bactericidal effect of silver-reinforced carbon nanotube and hydroxyapatite composites. J Biomater Appl 2013; 27:967–978.
44. Nath S, Kalmodia S, Basu B. Densification, phase stability and in vitro biocompatibility property of hydroxyapatite-10 wt% silver composites. J Mater Sci Mater Med 2010; 21:1273–1287.
45. Mandal S, Sunilkumar B, Kumar A, Basu B. Hot pressed silver doped hydroxyapatite biomaterials with bactericidal properties against magnetotactic bacteria. Mater Technol 2014; 29:B21–B25.
46. Singh B, Dubey AK, Kumar S, Saha N, Basu B, Gupta R. In vitro biocompatibility and antimicrobial activity of wet chemically prepared Ca10-xAgx(PO4)6(OH)2 (0.0
47. Saha N, Keskinbora K, Suvaci E, Basu B. Sintering, microstructure, mechanical, and antimicrobial properties of HAp-ZnO biocomposites. J Biomed Mater Res B Appl Biomater 2010; 95:430–440.
48. Saha N, Dubey AK, Basu B. Cellular proliferation, cellular viability, and biocompatibility of HA-ZnO composites. J Biomed Mater Res B Appl Biomater 2012; 100:256–264.
49. Bajpai I, Balani K, Basu B. Spark plasma sintered HA-Fe3O4-based multifunctional magnetic biocomposites. J Am Ceram Soc 2013; 96:2100–2108.
50. Bajpai I, Balani K, Basu B. Synergistic effect of static magnetic field and HA-Fe3O4 magnetic composites on viability of S. aureus and E. coli bacteria. J Biomed Mater Res B Appl Biomater 2014; 102:524–532.
51. Goodman SB, Yao Z, Keeney M, Yang F. The future of biologic coatings for orthopaedic implants. Biomaterials 2013; 34:3174–3183.
52. Yoda I, Koseki H, Tomita M, Shida T, Horiuchi H, Sakoda H, Osaki M. Effect of surface roughness of biomaterials on Staphylococcus epidermidis adhesion. BMC Microbiol 2014; 14:234.
53. Tang H, Cao T, Liang X, Wang A, Salley SO, McAllister J, III, et al. Influence of silicone surface roughness and hydrophobicity on adhesion and colonization of Staphylococcus epidermidis. J Biomed Mater Res A 2009; 88:454–463.
54. Banerjee I, Pangule RC, Kane RS. Antifouling coatings: recent developments in the design of surfaces that prevent fouling by proteins, bacteria, and marine organisms. Adv Mater 2011; 23:690–718.
55. May RM, Hoffman MG, Sogo MJ, Parker AE, O'Toole GA, Brennan AB, Reddy ST. Micro-patterned surfaces reduce bacterial colonization and biofilm formation in vitro: Potential for enhancing endotracheal tube designs. Clin Transl Med 2014; 16:8.
56. Schumacher JF, Long CJ, Callow ME, Finlay JA, Callow JA, Brennan AB. Engineered nanoforce gradients for inhibition of settlement (attachment) of swimming algal spores. Langmuir 2008; 24:4931–4937.
57. MacCallum N, Howell C, Kim P, Sun D, Friedlander R, Ranisau J, et al. Liquid-infused silicone as a biofouling-free medical material. ACS Biomater Sci Eng 2015; 1:43–51.
58. Epstein AK, Wong T-S, Belisle RA, Boggs EM, Aizenberg J. Liquid-infused structured surfaces with exceptional anti-biofouling performance. Proc Natl Acad Sci USA 2012; 109:13182–13187.
59. Su H-L, Chou C-C, Hung D-J, Lin S-H, Pao IC, Lin J-H, Huang F-L, Dong R-X, Lin J-J. The disruption of bacterial membrane integrity through ROS generation induced by nanohybrids of silver and clay. Biomaterials 2009; 30:5979–5987.
60. Tiller JC, Liao C-J, Lewis K, Klibanov AM. Designing surfaces that kill bacteria on contact. Proc Natl Acad Sci USA 2001; 98:5981–5985.
61. Hasan J, Crawford RJ, Ivanova EP. Antibacterial surfaces: the quest for a new generation of biomaterials. Trends Biotechnol 2013; 31:295–304.
62. Gera N, Doores S. Kinetics and mechanism of bacterial inactivation by ultrasound waves and sonoprotective effect of milk components. J Food Sci 2011; 76: M111–M119.
63. Crum LA. Comments on the evolving field of sonochemistry by a cavitation physicist. Ultrason Sonochem 1995; 2:S147–S152.
64. Hu Y, Zhang Z, Yang C. Measurement of hydroxyl radical production in ultrasonic aqueous solutions by a novel chemiluminescence method. Ultrason Sonochem 2008; 15:665–672.
65. Margulis MA, Margulis IM. Calorimetric method for measurement of acoustic power absorbed in a volume of a liquid. Ultrason Sonochem 2003;10:343–345.
66. Sesal NC, Kekec O. Inactivation of Escherichia coli and Staphylococcus aureus by ultrasound. J Ultrasound Med 2014; 33:1663–1668.
67. Mazzola P, Penna T, da S Martins A. Determination of decimal reduction time (D value) of chemical agents used in hospitals for disinfection purposes. BMC Infect Dis C7 - 24. 2003; 3:1–10.
68. Joyce E, Al-Hashimi A, Mason TJ. Assessing the effect of different ultrasonic frequencies on bacterial viability using flow cytometry. J Appl Microbiol 2011; 110:862–870.
69. Gao S, Hemar Y, Ashokkumar M, Paturel S, Lewis GD. Inactivation of bacteria and yeast using high-frequency ultrasound treatment. Water Res 2014; 60:93–104.
70. Wrenn SP, Small E, Dan N. Bubble nucleation in lipid bilayers: A mechanism for low frequency ultrasound disruption. Biochim Biophys Acta (BBA) - Biomem 2013; 1828:1192–1197.
71. Qian Z, Sagers RD, Pitt WG. The effect of ultrasonic frequency upon enhanced killing of P. aeruginosa biofilms. Ann Biomed Eng 1997; 25:69–76.
72. Rediske AM, Roeder BL, Brown MK, Nelson JL, Robison RL, Draper DO, Schaalje GB, Robison RA, Pitt WG. Ultrasonic enhancement of antibiotic action on Escherichia coli biofilms: an in vivo model. Antimicrob Agents Chemother. 1999; 43:1211–1214.
73. Justin TS, Thomas JW. Antibacterial effect of zinc oxide nanoparticles combined with ultrasound. Nanotechnology 2012; 23:495101.
74. Pitt WG, Husseini GA, Staples BJ. Ultrasonic drug delivery—A general review. Expert Opin Drug Deliv 2004; 1:37–56.
75. Noble ML, Mourad PD, Ratner BD. Digital drug delivery: on-off ultrasound controlled antibiotic release from coated matrices with negligible background leaching. Biomater Sci 2014; 2:893–902.
76. Mitragotri S. Healing sound: the use of ultrasound in drug delivery and other therapeutic applications. Nat Rev Drug Discov 2005; 4:255–260.
77. Ahmadi F, McLoughlin IV, Chauhan S, ter-Haar G. Bio-effects and safety of low-intensity, low-frequency ultrasonic exposure. Prog Biophys Mol Biol 2012; 108:119–138.
78. Liu H-L, Chen Y-Y, Chen W-S, Shih T-C, Chen J-S, Lin W-L. Interactions between consecutive sonications for characterizing the thermal mechanism in focused ultrasound therapy. Ultrasound Med Biol 2006; 32:1411–14121.
79. Liu H-L, Chen W-S, Chen J-S, Shih T-C, Chen Y-Y, Lin W-L. Cavitation-enhanced ultrasound thermal therapy by combined low- and high-frequency ultrasound exposure. Ultrasound Med Biol 2006; 32:759–767.
80. Miller DL, Smith NB, Bailey MR, Czarnota GJ, Hynynen K, Makin IR. Overview of therapeutic ultrasound applications and safety considerations. J Ultrasound Med 2012; 31:623–634.
81. Hong FT. Magnetic field effects on biomolecules, cells, and living organisms. Biosystems 1995; 36:187–229.
82. Binhi VN. 3 - Theoretical models of MBE. In: Magnetobiology. London: Academic Press; 2002. pp. 111–209.
83. Worcester DL. Structural origins of diamagnetic anisotropy in proteins. Proc Natl Acad Sci U S A 1978; 75:5475–5457.
84. Binhi VN. Interference of ion quantum states within a protein explains weak magnetic field's effect on biosystems. Electromag Biol Med 1997; 16:203–214.
85. Binhi VN. Interference mechanism for some biological effects of pulsed magnetic fields. Bioelectrochem Bioener 1998; 45:73–81
86. Binhi VN. 4—Interference of bound ions. In: Magnetobiology. London: Academic Press; 2002. pp 210–331.
87. Binhi VN, Alipov YD, Belyaev IY. Effect of static magnetic field on E. coli cells and individual rotations of ion-protein complexes. Bioelectromagnetics 2001; 22:79–86.
88. Ji W, Huang H, Deng A, Pan C. Effects of static magnetic fields on Escherichia coli. Micron 2009; 40:894–898.
89. Li SH, Chow KC. Magnetic field exposure induces DNA degradation. Biochem Biophys Res Commun 2001; 280:1385–1388.
90. Bajpai I, Saha N, Basu B. Moderate intensity static magnetic field has bactericidal effect on E. coli and S. epidermidis on sintered hydroxyapatite. J Biomed Mater Res B Appl Biomater 2012; 100:1206–1217.
91. Ikehata M, Koana T, Suzuki Y, Shimizu H, Nakagawa M. Mutagenicity and co-mutagenicity of static magnetic fields detected by bacterial mutation assay. Mutat Res/Fundament Mol Mech Mutagen 1999; 427:147–156.
92. Potenza L, Ubaldi L, De Sanctis R, De Bellis R, Cucchiarini L, Dachà M. Effects of a static magnetic field on cell growth and gene expression in Escherichia coli. Mutat Res/Gen Toxicol Environ Mutagen 2004; 561:53–62.
93. Shoogo U, Tsukasa S. Biological effects of static magnetic fields. Bioengineering and Biophysical Aspects of Electromagnetic Fields: CRC Press; 2006.
94. Vatansever F, de Melo WC, Avci P, Vecchio D, Sadasivam M, Gupta A, et al. Antimicrobial strategies centered around reactive oxygen species–bactericidal antibiotics, photodynamic therapy, and beyond. FEMS Microbiol Rev 2013; 37:955–989.
95. Boda SK, Ravikumar K, Saini DK, Basu B. Differential viability response of prokaryotes and eukaryotes to high strength pulsed magnetic stimuli. Bioelectrochem 2015; 106, Part B: 276–289.
96. Ghodbane S, Lahbib A, Sakly M, Abdelmelek H. Bioeffects of static magnetic fields: Oxidative stress, genotoxic effects, and cancer studies. BioMed Res Int 2013; 2013:602987.
97. Grissom CB. Magnetic field effects in biology: A survey of possible mechanisms with emphasis on radical-pair recombination. Chem Rev 1995; 95:3–24.
98. Balkenende AR, van de Boogaard HJAP, Scholten M, Willard NP. Evaluation of different approaches to assess the surface tension of low-energy solids by means of contact angle measurements. Langmuir 1998; 14:5907–5912.
99. Yeo S-H, Chua L-Y. Adhesion of Pseudomonas fluorescens on magnetic surfaces. Colloids Surf B Biointerfaces 2004; 36:75–80.
100. Chua L-Y, Yeo S-H. Surface bio-magnetism on bacterial cells adhesion and surface proteins secretion. Colloids Surf B Biointerfaces 2005; 40:45–49.
101. Boda SK, Thrivikraman G, Basu B. Magnetic field assisted stem cell differentiation—Role of substrate magnetization in osteogenesis. J Mater Chem B 2015; 3:3150–3168.
102. Asadi MR, Torkaman G. Bacterial inhibition by electrical stimulation. Adv Wound Care 2014; 3:91–97.
103. Valic B, Pavlin M, Miklavcic D. The effect of resting transmembrane voltage on cell electropermeabilization: a numerical analysis. Bioelectrochem 2004; 63(1-2):311–315.
104. Shapiro HM. Membrane potential estimation by flow cytometry. Methods 2000; 21:271–279.
105. Alberts B, Johnson A, Lewis J, Raff M, Roberts K, Walter P. Molecular Biology of the Cell. 4th ed. Ion Channels and the Electrical Properties of Membranes. New York: Garland Science; 2002.
106. Harold FM, Baarda JR. Gramicidin, valinomycin, and cation permeability of Streptococcus faecalis. J Bacteriol 1967; 94:53–60.
107. Valic B, Golzio M, Pavlin M, Schatz A, Faurie C, Gabriel B, Teissie J, Rols MP, Miklavcic D. Effect of electric field induced transmembrane potential on spheroidal cells: theory and experiment. Eur Biophys J 2003; 32:519–528.
108. Shapiro HM. Estimation of membrane potential by flow cytometry. Curr Protoc Cytom 2004;Chapter 9:Unit 96.
109. Costerton JW, Ellis B, Lam K, Johnson F, Khoury AE. Mechanism of electrical enhancement of efficacy of antibiotics in killing biofilm bacteria. Antimicrob Agents Chemother 1994; 38:2803–2809.
110. Blenkinsopp SA, Khoury AE, Costerton JW. Electrical enhancement of biocide efficacy against Pseudomonas aeruginosa biofilms. Appl Environ Microbiol 1992; 58:3770–3773.
111. Hulsheger H, Potel J, Niemann EG. Electric field effects on bacteria and yeast cells. Radiat Environ Biophys 1983; 22:149–162.
112. Toepfl S, Heinz V, Knorr D. High intensity pulsed electric fields applied for food preservation. Chem Eng Process Process Intensif 2007; 46:537–546.
113. Ercan B, Kummer KM, Tarquinio KM, Webster TJ. Decreased Staphylococcus aureus biofilm growth on anodized nanotubular titanium and the effect of electrical stimulation. Acta Biomater 2011; 7:3003–3012.
114. Gall I, Herzberg M, Oren Y. The effect of electric fields on bacterial attachment to conductive surfaces. Soft Matter 2013; 9:2443–2452.
115. Hong SH, Jeong J, Shim S, Kang H, Kwon S, Ahn KH, Yoon J. Effect of electric currents on bacterial detachment and inactivation. Biotechnol Bioeng 2008; 100:379–386.
116. Jain S, Sharma A, Basu B. Vertical electric field induced bacterial growth inactivation on amorphous carbon electrodes. Carbon 2015; 81:193–202.
117. Boda SK, Bajpai I, Basu B. Inhibitory effect of direct electric field and HA-ZnO composites on S. aureus biofilm formation. J Biomed Mater Res B: Appl Biomater 2015: n/a–n/a.
118. Liu WK, Brown MR, Elliott TS. Mechanisms of the bactericidal activity of low amperage electric current (DC). J Antimicrob Chemother 1997; 39:687–695.
119. Dubey AK, Gupta SD, Basu B. Optimization of electrical stimulation parameters for enhanced cell proliferation on biomaterial surfaces. J Biomed Mater Res B Appl Biomater 2011; 98:18–29.
120. Dubey AK, Agrawal P, Misra RD, Basu B. Pulsed electric field mediated in vitro cellular response of fibroblast and osteoblast-like cells on conducting austenitic stainless steel substrate. J Mater Sci Mater Med 2013; 24:1789–1798.
121. Dubey AK, Basu B. Pulsed electrical stimulation and surface charge induced cell growth on multistage spark plasma sintered hydroxyapatite-barium titanate piezobiocomposite. J Am Ceram Soc 2014; 97:481–489.
122. Jain S, Sharma A, Basu B. Vertical electric field stimulated neural cell functionality on porous amorphous carbon electrodes. Biomaterials 2013; 34:9252–9263.
123. Thrivikraman G, Madras G, Basu B. Intermittent electrical stimuli for guidance of human mesenchymal stem cell lineage commitment towards neural-like cells on electroconductive substrates. Biomaterials 2014; 35:6219–6235.
124. Thrivikraman G, Madras G, Basu B. Electrically driven intracellular and extracellular nanomanipulators evoke neurogenic/cardiomyogenic differentiation in human mesenchymal stem cells. Biomaterials 2015; 77:26–43.